BioCardia, Inc. (BCDA)

BioCardia Statistics

Total Valuation

BioCardia has a market cap or net worth of $14.45 million. The enterprise value is $13.08 million.

Market Cap	14.45M
Enterprise Value	13.08M

Important Dates

The next confirmed earnings date is Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

BioCardia has 5.09 million shares outstanding. The number of shares has increased by 94.32% in one year.

Current Share Class	5.09M
Shares Outstanding	5.09M
Shares Change (YoY)	+94.32%
Shares Change (QoQ)	+62.25%
Owned by Insiders (%)	23.43%
Owned by Institutions (%)	4.44%
Float	3.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	134.83
Forward PS	n/a
PB Ratio	15.67
P/TBV Ratio	17.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	225.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.14.

Current Ratio	1.13
Quick Ratio	1.02
Debt / Equity	1.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-149.03%
Return on Invested Capital (ROIC)	-666.75%
Return on Capital Employed (ROCE)	-570.28%
Revenue Per Employee	$2,900
Profits Per Employee	-$397,300
Employee Count	20
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.17% in the last 52 weeks. The beta is 0.91, so BioCardia's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-52.17%
50-Day Moving Average	2.40
200-Day Moving Average	2.47
Relative Strength Index (RSI)	60.46
Average Volume (20 Days)	91,972

Short Selling Information

The latest short interest is 137,005, so 2.69% of the outstanding shares have been sold short.

Short Interest	137,005
Short Previous Month	39,850
Short % of Shares Out	2.69%
Short % of Float	3.61%
Short Ratio (days to cover)	1.12

Income Statement

In the last 12 months, BioCardia had revenue of $58,000 and -$7.95 million in losses. Loss per share was -$2.90.

Revenue	58,000
Gross Profit	-4.33M
Operating Income	-8.00M
Pretax Income	n/a
Net Income	-7.95M
EBITDA	-7.93M
EBIT	-8.00M
Loss Per Share	-$2.90

Balance Sheet

The company has $2.37 million in cash and $951,000 in debt, giving a net cash position of $1.42 million or $0.28 per share.

Cash & Cash Equivalents	2.37M
Total Debt	951,000
Net Cash	1.42M
Net Cash Per Share	$0.28
Equity (Book Value)	837,000
Book Value Per Share	0.18
Working Capital	301,000

Cash Flow

In the last 12 months, operating cash flow was -$8.03 million and capital expenditures -$6,000, giving a free cash flow of -$8.03 million.

Operating Cash Flow	-8.03M
Capital Expenditures	-6,000
Free Cash Flow	-8.03M
FCF Per Share	-$1.58

Margins

Gross Margin	n/a
Operating Margin	-13,794.83%
Pretax Margin	-13,700.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-94.32%
Shareholder Yield	n/a
Earnings Yield	-54.81%
FCF Yield	-55.40%

Analyst Forecast

The average price target for BioCardia is $25.00, which is 780.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	780.28%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	248.63%
EPS Growth Forecast (5Y)	-22.39%

Stock Splits

The last stock split was on May 30, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	May 30, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

BioCardia has an Altman Z-Score of -65.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-65.25
Piotroski F-Score	1